drugs
Gilead agrees to pay $97 million to settle Medicare kickbacks case
September 24, 2020Business Services Gilead, Medicare, drugs, kickbacks
Gilead has agreed to pay $97 million to resolve claims from the US Government that it used an independent charity …
Leading pharmaceutical companies sued in US for conspiring to drive up generics prices
June 11, 2020Business Services drugs, generics, lawsuit, price fixing, price-fixing
26 pharmaceutical companies are being sued by most US states for allegedly conspiring to reduce competition and drive up generic …
Coronavirus pandemic puts UK’s post-Brexit drug stockpile at risk
June 8, 2020Sales and Marketing COVID-19, coronavirus, drugs
The pharmaceutical industry has warned the UK government that certain stockpiles of medicine have been used up due to the …
India considering export restrictions on antibiotics due to coronavirus
February 17, 2020Sales and Marketing Chinese Coronavirus, Indian Pharma, Wuhan, china coronavirus, coronavirus, drugs
The Indian government is considering an export ban on antibiotics, vitamins and hormones due to the lockdown of Hubei province, …
Global drug market’s production line threatened by coronavirus
February 14, 2020Medical Communications Chinese Coronavirus, Drug markets, Wuhan Coronavirus, china epidemic, coronavirus, drugs, epidemic, pharma
The global drug market is facing issues over production due to the coronavirus ravaging the supply line from China. In …
Idorsia reveals it is working with Neurocrine on new epilepsy drug deal
January 10, 2020Medical Communications FDA, Idorsia, Neurocrine, drugs, epilepsy, pharma
Idorsia revealed its 2019 deal for its investigational epilepsy medicine was with Neurocrine Biosciences, and it is potentially worth more …
Novartis’ $2.15m SMA drug Zolgensma becomes most expensive FDA-approved therapy
May 28, 2019Manufacturing and Production AveXis, FDA, Zolgensma, access, drugs, pricing, sma
The FDA has approved Novartis subsidiary AveXis’ $2.15 million gene therapy Zolgensma for children with spinal muscular atrophy (SMA). The …
Patients to recieve MDMA-assisted psychotherapy on ‘compassionate’ grounds in Israel
February 28, 2019Research and Development MDMA, PTSD, drugs, mental health, psychedelics
The Israeli Health Ministry has approved the compassionate use of MDMA-assisted psychotherapy for 50 patients with post-traumatic stress disorder (PTSD). …
UK launches drug testing service for illicit drugs
February 25, 2019Sales and Marketing Home office, UK, cocaine, drugs, fentanyl, illicit substances, recreational drugs
The UK Home Office have licensed a drug-checking service for users of illicit substances. The yearlong pilot project, run by …
Teva settles ‘pay-to-delay’ case with FTC
February 21, 2019Business Services, Sales and Marketing FTC, Teva, antitrust, drugs, generics, monopoly
Teva Pharmaceuticals has settled a dispute with the Federal Trade Commission (FTC) over three separate federal court antitrust lawsuits involving …
GSK announces results of three year trial into long-lasting HIV injection
October 30, 2018Manufacturing and Production GSK, HIV, drugs, injection, medication
GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the …
President Trump pledges to fight drug addiction at UN meeting
September 25, 2018Manufacturing and Production Trump, UN, drugs, illicit drugs, trafficking
President Donald Trump has pledged to fight “the scourge of drug addiction,” as he outlined his commitment to the fight …
Life expectancy falls in America; drugs, alcohol and suicide to blame
September 24, 2018Sales and Marketing USA, alcohol, drugs, health, opiod crisis, suicide
Life expectancy has fallen for the second year in a row for people in the United States, according to new …
PTC Therapeutics’ results in SMA has Biogen nervous
June 19, 2018Manufacturing and Production, Research and Development Biogen, PTC Therapeutics, biotech, drugs, pharma, pharmaceutical
Biogen currently has the only product on the market approved to treat spinal muscular atrophy (SMA), in Spinraza, and that …
Roche buys out rest of Foundation Medicine for $2.4bn
June 19, 2018Manufacturing and Production, Sales and Marketing Foundation Medicine, Roche, biotech, drugs, pharma, pharmaceutical
Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership …
Latest content
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner
